SCHEMBL6712296

SCHEMBL6712296

OCc1cccc(-c2ccc3cc4n(c3c2)CCNCC4)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 5/20 0.54
HTR2C P28335 5/20 0.54
TGFB2 P61812 1/20 0.40
PARP1 P09874 1/20 0.40
ACMSD Q8TDX5 1/20 0.38
ALOX5 P09917 1/20 0.38
PRKCI P41743 1/20 0.37
PIK3CA P42336 1/20 0.36
MTOR P42345 1/20 0.36
PIK3CG P48736 1/20 0.36
CHEK1 O14757 1/20 0.36
HTR1A P08908 2/20 0.35
HTR7 P34969 2/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA7 P36544 1/20 0.35
CDK8 P49336 1/20 0.35
IKBKB O14920 1/20 0.35
CHUK O15111 1/20 0.35
ABL1 P00519 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6714252 0.91 HTR2A (0.54) HTR2AHTR2CTGFB2PARP1ACMSD
SCHEMBL6711148 0.85 HTR2A (0.51) HTR2AHTR2CPARP1CHEK1HTR1A
SCHEMBL6718264 0.85 HTR2A (0.51) HTR2AHTR2CCHEK1HTR1AHTR7
SCHEMBL6711322 0.83 HTR2A (0.68) HTR2AHTR2CHTR1AHTR7
SCHEMBL6713998 0.81 HTR2C (0.58) HTR2AHTR2CHTR1AHTR7
SCHEMBL6715232 0.80 HTR2A (0.47) HTR2AHTR2CTGFB2PARP1ALOX5
SCHEMBL6715445 0.80 HTR2A (0.71) HTR2AHTR2CHTR1AHTR7
SCHEMBL6712234 0.80 HTR2A (0.56) HTR2AHTR2CALOX5CHRM3
SCHEMBL6711417 0.79 HTR2A (0.55) HTR2AHTR2CCHEK1CDK8
SCHEMBL6713778 0.79 HTR2C (0.54) HTR2AHTR2CPARP1ALOX5HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040209870-A1 Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds ENNIS MICHAEL DALTON (US) 2004-10-21 US disclosed
US-20020002161-A1 Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds PHARMACIA & UPJOHN COMPANY 2002-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020002161-A1 Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds HTR1D, HTR1A, HTR1E HTR2A 18/4885HTR2C 7/4885TGFB2 4756/4885
US-20040209870-A1 Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds HCRTR2, NR2C2, RCOR3 HTR2A 1403/4885HTR2C 553/4885TGFB2 3004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.